The A2LA blog is a resource for information related to the accreditation industry, international standards, the role of accreditation in life and business, and A2LA as an organization. It includes informational articles about accreditation concepts, spotlights on A2LA-accredited organizations, and important updates about A2LA and the accreditation industry overall. Our writers and collaborators strive to provide content that is accurate, informative, consistent, and clear to best serve those seeking to learn. Do you have a special request or an idea for a topic? Please contact marketing@A2LA.org.
A2LA is proud to announce the launch of its new Biobank Accreditation Program.
Lonnie Spires, A2LA’s President/CEO, was recognized by Frederick County Office of Economic Development (OED) as one of the Top 50 CEOs in 2018.
A2LA is pleased to announce the renewal of accreditation of Phenova based in Golden, Colorado. Phenova is A2LA’s first ISO/IEC 17043 accredited Proficiency Testing Provider for cannabis.
A2LA provided Clinical Laboratory Improvement Program (CLIP) Accreditation to the US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD
EVIO Labs Massachusetts is based in Southborough, MA, and is the first cannabis testing laboratory accredited by A2LA in the state.
A2LA Reapproved by Centers for Medicare & Medicaid Services as an Accreditation Organization Under the CLIA 88
A2LA is the only accreditation body in the world holding the highest level of formal clinical laboratory accreditation recognitions: CMS CLIA Deemed Status and International Laboratory Accreditation Cooperation (ILAC) Recognition.